Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

16.97 -0.30 (-1.74%)

Delayed Quote Updated: 12:33 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Summit Therapeutics Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Why Alphabet And Amazon Are Trading Lower; Here Are 20 Stocks Moving Premarket ↗

February 03, 2023

Gainers Nordstrom Inc. (NYSE: JWN) shares surged 29.56% to $27.39 in pre-market trading after activist investor Ryan Cohen took a stake in the company and announced he is planning to urge a board...

Via Benzinga

Summit Therapeutics Announces Timing for Rights Offering for Up to $500 Million

January 30, 2023

From Summit Therapeutics Inc.

Via Business Wire

Week In Review: HutchMed Announces $1.1 Billion Deal With Takeda For Colorectal Cancer Drug ↗

January 28, 2023

Shanghai’s HutchMed out-licensed global rights for a colorectal cancer therapy to Japan’s Takeda in a deal worth up to $1.13 billion, including $400 million upfront. In addition to the $1.13 billion,...

Via Talk Markets

Why Summit Therapeutics Shares Soared This Week ↗

December 30, 2022

The clinical-stage biopharma stock has been rising all year.

Via The Motley Fool

Why Summit Therapeutics Stock Is Skyrocketing This Week ↗

December 08, 2022

The company announced an important licensing deal.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 27, 2023

Via Benzinga

Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody

January 20, 2023

From Summit Therapeutics Inc.

Via Business Wire

How Is The Market Feeling About Summit Therapeutics? ↗

January 13, 2023

Summit Therapeutics's (NASDAQ:SMMT) short percent of float has fallen 21.45% since its last report. The company recently reported that it has 3.96 million shares sold short, which is 14.06% of all...

Via Benzinga

Summit Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 05, 2023

From Summit Therapeutics Inc.

Via Business Wire

Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 10, 2023

Gainers

Via Benzinga

Vera Therapeutics, Phathom Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

January 04, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank? ↗

January 03, 2023

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 30, 2022

Via Benzinga

Futu Holdings, UP Fintech Holding And Some Other Big Stocks Moving Lower On Friday ↗

December 30, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Dow Tumbles 150 Points; Crude Oil Falls Sharply ↗

December 28, 2022

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday.

Via Benzinga

Gorilla Technology And Some Other Big Stocks Moving Higher On Wednesday ↗

December 28, 2022

U.S. stocks traded lower, with the Dow Jones dropping around 40 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

US Stocks Rise; Dow Gains 100 Points ↗

December 28, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.

Via Benzinga

Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday ↗

December 20, 2022

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday ↗

December 19, 2022

U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

December 19, 2022

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 14, 2022

Via Benzinga

Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 14, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

Via Benzinga

Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact ↗

December 10, 2022

In a blockbuster agreement, Guangzhou’s Akeso out-licensed ex-China rights to its bispecific PD-1/VEGF candidate in a deal worth up to $5 billion. Summit Therapeutics will pay $500 million upfront and...

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 08, 2022

Via Benzinga

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

Why My Size Shares Are Trading Higher By Around 64%; Here Are 24 Stocks Moving Premarket ↗

December 08, 2022

Gainers My Size, Inc. (NASDAQ: MYSZ) shares rose 63.5% to $0.2469 in pre-market trading. My Size announced a 1-for-25 reverse stock split.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 08, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 08, 2022

We're starting off the day with a look at the biggest pre-market stock movers that traders will want to watch on Thursday!

Via InvestorPlace

Peering Into Summit Therapeutics's Recent Short Interest ↗

December 07, 2022

Summit Therapeutics's (NASDAQ:SMMT) short percent of float has fallen 9.09% since its last report. The company recently reported that it has 260 thousand shares sold short, which is 0.2% of all regular...

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.